Bridging the gap between R&D and commercial deployment for solvent-assisted SAGD—systematically isolating subsurface risk, protecting indigenous water sources, and charting a viable path from lab concept to field-scale economics.

A major oil sands operator had invested years in developing Enhanced Solvent-Assisted SAGD (ES-SAGD)—a technology concept dating back to the 1970s that uses solvent co-injection to improve bitumen recovery efficiency. Despite promising lab results and pilot data, the technology remained stuck between R&D and commercial deployment. The conventional approach—running technology development and commercial planning in separate swim lanes—had produced research outputs but no deployable, economically viable solution. An integrated effort was required to bridge that gap: translating decades of technical work into a commercial asset with clear risk boundaries and a viable path to field-scale economics.
Delivered a commercially viable ES-SAGD deployment framework with clearly bounded risk—moving the technology from decades of R&D stall into a field-ready, sanction-grade asset with validated economics and regulatory support.
Indigenous water sources and aquifer integrity were safeguarded through transparent engagement, independent expert validation, and verifiable mitigation measures—earning stakeholder trust and regulatory confidence before any field operations commenced.
Established a replicable decision framework for technology commercialization—clearly defining where ES-SAGD was commercially viable, where risks remained too high, and how to structure ongoing de-risking efforts within a disciplined capital allocation process.
Whether it's commercializing a new technology, bridging the gap between R&D and field deployment, or navigating complex stakeholder and regulatory landscapes—this is the kind of integrated, risk-disciplined approach that protects capital and unlocks value.